浙江中西医结合杂志
浙江中西醫結閤雜誌
절강중서의결합잡지
ZHEJIANG JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2013年
7期
526-529,534
,共5页
许晓峰%张学进%程汝滨%高瑞兰
許曉峰%張學進%程汝濱%高瑞蘭
허효봉%장학진%정여빈%고서란
人原代白血病细胞%萝卜硫素%化疗药%敏感性
人原代白血病細胞%蘿蔔硫素%化療藥%敏感性
인원대백혈병세포%라복류소%화료약%민감성
human leukemia primary cells%sulforaphane%chemotherapeutic drugs%sensitivity
目的:探讨萝卜硫素(SF)对白血病细胞化疗药物敏感性的作用。方法:琼脂半固体集落培养法和MTT法检测不同浓度的萝卜硫素对HL-60细胞增殖的影响及协同化疗药对细胞生长的抑制作用;PHA-LCM液相原半固体二步培养SF协同化疗药抑制人原代白血病细胞生长。结果:琼脂半固体集落培养法和MTT法证实在一定浓度范围内SF对HL-60细胞增殖抑制(P<0.05,P<0.01),呈剂量依赖性,SF能够增强HL-60细胞对化疗药物高三尖杉酯碱(Hom)和阿糖胞苷(Ara-c)敏感性(P<0.05);PHA-LCM液相原半固体二步培养法证实SF在一定浓度范围内对人原代白血病细胞有抑制作用(P<0.05,P<0.01),呈剂量依赖性,并增加人原代白血病细胞对化疗药Hom和Ara-c敏感性。结论:萝卜硫素在一定浓度下有效抑制白血病细胞增殖,并能增强化疗药物的敏感性。
目的:探討蘿蔔硫素(SF)對白血病細胞化療藥物敏感性的作用。方法:瓊脂半固體集落培養法和MTT法檢測不同濃度的蘿蔔硫素對HL-60細胞增殖的影響及協同化療藥對細胞生長的抑製作用;PHA-LCM液相原半固體二步培養SF協同化療藥抑製人原代白血病細胞生長。結果:瓊脂半固體集落培養法和MTT法證實在一定濃度範圍內SF對HL-60細胞增殖抑製(P<0.05,P<0.01),呈劑量依賴性,SF能夠增彊HL-60細胞對化療藥物高三尖杉酯堿(Hom)和阿糖胞苷(Ara-c)敏感性(P<0.05);PHA-LCM液相原半固體二步培養法證實SF在一定濃度範圍內對人原代白血病細胞有抑製作用(P<0.05,P<0.01),呈劑量依賴性,併增加人原代白血病細胞對化療藥Hom和Ara-c敏感性。結論:蘿蔔硫素在一定濃度下有效抑製白血病細胞增殖,併能增彊化療藥物的敏感性。
목적:탐토라복류소(SF)대백혈병세포화료약물민감성적작용。방법:경지반고체집락배양법화MTT법검측불동농도적라복류소대HL-60세포증식적영향급협동화료약대세포생장적억제작용;PHA-LCM액상원반고체이보배양SF협동화료약억제인원대백혈병세포생장。결과:경지반고체집락배양법화MTT법증실재일정농도범위내SF대HL-60세포증식억제(P<0.05,P<0.01),정제량의뢰성,SF능구증강HL-60세포대화료약물고삼첨삼지감(Hom)화아당포감(Ara-c)민감성(P<0.05);PHA-LCM액상원반고체이보배양법증실SF재일정농도범위내대인원대백혈병세포유억제작용(P<0.05,P<0.01),정제량의뢰성,병증가인원대백혈병세포대화료약Hom화Ara-c민감성。결론:라복류소재일정농도하유효억제백혈병세포증식,병능증강화료약물적민감성。
Objective: To investigate the effect of sulforaphane (SF) on chemotherapy sensitivity of leukemia cells. Methods: Semi-solid agar colony culture assay and MMT method were used to observe the effect of different con-centrations of SF on HL-60 cell proliferation and homoharringtonine+ ara-c chemotherapy on cell growth. PHA-LCM two-stage culture method was used to detect the effect of SF and homoharringtonine+ara-c chemotherapy on human primary leukemia cells. Results: With a certain range of concentrations, SF inhibited the proliferation of HL-60 cells and the growth of human primary leukemia cells in a dose-dependent manner (P<0.05,P<0.01). SF enhanced homoharringtonine+ara-c chemotherapy sensitivity of HL-60 cells (P<0.05) and human primary leukemia cells. Conclusion: SF can inhibit the proliferation of leukemia cells with a certain range of concentrations and en-hance chemotherapy sensitivity of these cells.